Sarcopenia and Related Factors in Patients With Multiple Sclerosis
Launched by SELCUK UNIVERSITY · Aug 4, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how common sarcopenia—a condition that causes loss of muscle strength and mass—is in people with Multiple Sclerosis (MS). MS is a disease that affects the nervous system and can lead to problems with movement and muscle weakness. The study aims to understand how sarcopenia relates to symptoms like tiredness, disability level, nutrition, and physical activity in people with MS. Researchers want to learn more about muscle strength, body changes, and how diet and exercise might affect muscle health in this group.
People who are 18 years or older, have a confirmed diagnosis of MS, are currently stable (no recent attacks), and can still walk with some independence may be eligible to join. Participants will be asked to undergo tests that measure muscle strength, physical abilities, and body composition, as well as provide information about their nutrition and activity levels. This study hopes to find ways to detect muscle loss early and improve quality of life for people living with MS. If you meet the eligibility criteria and are interested, this study is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 18 years of age or older,
- • Having been diagnosed with Multiple Sclerosis (confirmed by a neurologist),
- • Being in a stable phase of the disease (having not had an attack in the last 3 months),
- • Having preserved walking ability (EDSS score ≤6.5),
- • Being able to give informed consent to participate in the study.
- Exclusion Criteria:
- • Having another neuromuscular disease.
- • Having developed significant muscle loss within the last 6 months due to use of corticosteroids or immunosuppressive therapy.
- • Having systemic diseases that can cause muscle loss, such as cancer, rheumatic diseases, or severe metabolic disorders.
- • Having undergone major surgery or a history of serious trauma within the last 3 months.
- • Being pregnant or breastfeeding.
About Selcuk University
Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, Selcuklu, Turkey
Patients applied
Trial Officials
İsmail ÖZSOY, Assoc. Prof. Dr.
Principal Investigator
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye
Haluk GÜMÜŞ, Prof. Dr.
Study Chair
Selçuk University, Faculty of Medicine, Department of Neurology, Konya, Türkiye
Gülşah ÖZSOY, Assist. Prof. Dr.
Study Chair
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye
Zehra KORKUT, Assist. Prof. Dr.
Study Chair
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye
Yasemin GEDİKLİ, Res. Asst.
Study Chair
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye
Emel A ATAMAN AKTAŞ, Dr.
Study Chair
Selçuk University, Faculty of Medicine, Department of Neurology, Konya, Türkiye
Omar E QUTOB, Dr.
Study Chair
Selçuk University, Faculty of Medicine, Department of Neurology, Konya, Türkiye
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported